Dottikon ES Holding stock
DESN.SWSIXDottikon ES Holding AG, Basic MaterialsISIN CH0582581713
61Score 61 out of 100, Neutral
Price and trend
57 / 100
Price history
−7.5% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 4.3% below it.
Since June 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Overheated: the price has risen very quickly lately (RSI 74).
The price is 26% below its 52-week high. Largest decline in 20 years: 54% (November 2021 to April 2025).
Chart figures for advanced users
- SMA 50$322.74
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$365.66
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)74
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$304.87
- The lowest closing price of the last twelve months.
- Resistance$470.51
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Dottikon ES Holding AG belongs to the Chemicals (Specialty) industry (Switzerland) and, with a market value of $4.84B, is number 67 of 106 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $514.24M (up 11.2% year on year) and earnings of $124.35M (down 1.9%).
- MEQIRI Score 61 out of 100 (Neutral): rank 187 of 461 in Basic Materials, median 57.
Show more
- The P/E is 38.9 (Chemicals (Specialty) median 24.4, own median of recent years 38).
- Our model puts fair value at $219.75, with the price 59% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- High marginNet margin 24.2% over the last 12 months, Chemicals (Specialty) median 4.9%.Profitability 67
- Consistently profitableProfit in all 10 fiscal years from 2016 to 2025.Fundamentals 53
- Growing faster than its industryRevenue up 14.4% a year since 2020, Chemicals (Specialty) median 6%.Growth 80
Weaknesses
- Above fair valuePrice 59% above the fair value of $219.75.Valuation 26
Its standout strengths are stability and growth, while capital allocation and valuation hold the score back.
Daily figure as of 13 Nov 2026
How the score is calculatedScore overview
The fundamentals are in the middle range.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk high
How well MEQIRI warnsOne of the 30% with the highest crash risk among smaller stocks.
From 2016 to 2025, 36 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- cyclical sector (energy or materials), as a group, crashed more often in the backtest
What lowers it
- calm price action
Valuation
Valuation signal
Significantly overvaluedIn our model the price counts as cheap below $169.04 and expensive above $313.93 (uncertainty medium, based on the price swings of the past year).
Valuation metrics
From earnings times the industry P/E (24.4) alone; there are no viable cash flows for the cash-flow model.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In fiscal 2025, revenue rose 11.2% on the prior year. Revenue has grown solidly since 2006, at about 6% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 64%, operating 27%, net 24%.
Debt & balance sheet
latest quarterThe balance sheet is solid, with low debt and comfortable interest coverage.
Earnings
- Next earnings
- 27 Nov 2026in 14 days
- Last reported
- 29 May 2026EPS reported $4.86
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- $9.370.0%
- Revenue
- $561.41M0.0%
- Earnings per share
- $11.200.0%
- Revenue
- $632.23M0.0%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
What happened at Dottikon ES Holding
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
461 rated companies in Basic Materials
- This company
- 61
- Sector median
- 57
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next larger and next smaller companies by market value
- LB Group002601.SZ $5.33B45
- ArkemaAKE.PA $4.99B50
- Sensient TechnologiesSXT $4.94B58
- Perimeter SolutionsPRM $4.85B56
- Wacker ChemieWCH.DE $4.52B46
- ClariantCLN.SW $4.38B60
- AvientAVNT $4.12B61
- CabotCBT $3.71B61
ETFs that hold Dottikon ES Holding
Held by 8 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Amundi MSCI Europe Small Cap ESG Broad Transition UCITS ETF DistX026 | 0.12% | 0.23% | €321.86M |
| iShares Healthcare Innovation UCITS ETF2B78 | 0.11% | 0.40% | €1.5B |
| Xtrackers MSCI Europe Small Cap UCITS ETF 1CXXSC | 0.06% | 0.30% | €3.45B |
Show 4 more
| State Street SPDR MSCI Europe Small Cap Value Weighted UCITS ETF EUR AccZPRX | 0.01% | 0.30% | €813.64M |
| State Street SPDR MSCI World Small Cap UCITS ETF (Acc)ZPRS | 0.01% | 0.45% | €1.54B |
| Vanguard ESG Global All Cap UCITS ETF (USD) AccumulatingV3AA | 0.00% | 0.24% | €1.69B |
| Vanguard FTSE Global All-Cap UCITS ETF Accum USDVGLA | 0.00% | 0.07% | €3.9B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Mar 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = CHF 0.8331)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 29 May 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.